文献速递临床试验与 GCP医学教育与科研方法

常见临床试验修正案、提交原因及避免方法:一项针对英国国家医疗服务体系资助研究的混合方法研究(修正案集结)

Common Clinical Trial Amendments, why they are submitted and how they can be avoided: a mixed methods study on NHS UK Sponsored Research (Amendments Assemble).
PubMed 文献 · Trials · 2023-01-04

本研究采用解释性序列混合方法,分析2009年9月至2020年3月间某大学医院NHS信托资助试验中242份获批修正案,并对11名试验利益相关者进行半结构化访谈。最常见修正类型为「增加研究中心」,最常见原因为「达到试验招募目标」;可避免修正的根因包括急于提交初始申请、未让所有关键人员参与、实施中发现不可行及监管核查缺失。作者认为试验需经多方严格审查并预留足够时间进行规划与可行性评估,以避免部分修正。

要点

  • 最常见修正类型为「增加研究中心」,最常见原因为「达到试验招募目标」。
  • 可避免修正的根因包括急于提交初始申请、未让所有关键人员参与、实施中发现不可行。
  • 作者认为需多方严格审查并预留足够时间进行规划与可行性评估以避免部分修正。

核心结论

  • 试验需经多方利益相关者严格审查并预留足够时间进行规划与可行性评估,以避免部分修正,从而提高临床试验效率并使参与者、研究者、资助方、申办方和监管机构受益,可能更快为患者带来新治疗。

研究设计与样本

  • 采用解释性序列混合方法设计,第一环节对2009年9月至2020年3月间某大学医院NHS信托资助试验中提交的修正案样本进行内容分析,第二环节对试验利益相关者的半结构化访谈进行主题分析。
  • 共检查来自53项临床研究研究的242份获批修正案,并访谈11名利益相关者。

主要发现

  • 最常见修正类型为「增加研究中心」,最常见修正原因为「达到试验招募目标」。
  • 11名受访者识别的可避免修正根因包括「急于提交初始申请,明知后续需要修正」「试验开始时未让所有关键人员参与投入」以及「实施试验时意识到实际不可行」。
  • 在繁重且易出错的申请流程之后缺失监管核查也被识别为部分修正的原因。

临床怎么用

  • 作者认为试验需经多方利益相关者严格审查并预留足够时间进行规划与可行性评估,以避免部分修正。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Amendments are changes made to a clinical trial after it has received regulatory approval. An amendment can take a significant amount of time and resources to develop, review and implement at participating sites. This can affect the efficient delivery of clinical trials and potentially contribute to research waste. This study aimed to establish what the most common amendments are, why they are submitted, and what, if anything, can be done to avoid them. METHODS: An explanatory sequential mixed methods design was employed. The first strand involved a content analysis on a sample of amendments, submitted in trials sponsored by a University Hospital NHS Trust between September 2009 and March 2020, to establish the most common changes and reasons for amendments. The second strand involved thematically analysing semi-structured interviews with trial stakeholders to explore their views on the reasons underpinning the submission of amendments, and the potential for efficiencies that could prevent avoidable amendments. RESULTS: Two hundred forty-two approved amendments were examined from 53 clinical research studies. The 'Addition of sites' was the most common amendment change, and the most common reason for amendments was 'To achieve the trial's recruitment target'. The root causes for avoidable amendments identified by the 11 interviewees included the following: 'Rushing the initial application knowing an amendment will be needed later', 'Not involving all the right people to input' at the start of the trial, and 'Realising it's not feasible in practice when delivering the trial'. Missing regulatory checks following an onerous and error-prone application process were also identified as the cause of some amendments. CONCLUSIONS: Trials need to be critically reviewed by various stakeholders and have sufficient time allocated to planning and feasibility assessments to avoid some amendments. This may improve clinical trial efficiency, to benefit the trial participants, researchers, funders, sponsors, and regulatory bodies, and potentially bring new treatments to patients faster.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Joshi S. Common Clinical Trial Amendments, why they are submitted and how they can be avoided: a mixed methods study on NHS UK Sponsored Research (Amendments Assemble). Trials. 2023. PMID: 36600286. doi:10.1186/s13063-022-06989-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。